Navigation Links
Data Safety Monitoring Board Unanimously Recommends Continuation of Delcath's Phase III Clinical Trial
Date:9/11/2009

NEW YORK, Sept. 11 -- /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced that the Data and Safety Monitoring Board ("DSMB") reviewed clinical data on 77 patients enrolled in its pivotal Phase III clinical trial and unanimously recommended that the trial continue to enroll patients with the goal of reaching the 92 patients required to complete the study. In addition, the Company announced it now expects enrollment to be completed by mid-October.

Eamonn Hobbs, President and CEO of Delcath Systems stated, "We are pleased by the successful review of our safety data and the recent, accelerated pace of enrollment, which has put us in the trial's home stretch. This is an exciting time for the Company. With current enrollment trends, we now expect to complete enrollment by the middle of October and are still on track for an FDA submission by mid-2010."

The DSMB is an independent group of experts with the responsibility for reviewing and evaluating the safety and response data generated from the Company's Phase III trial. The primary responsibilities of the DSMB are to ensure the safety of all patients enrolled in the trial, the quality of the data collected and the continued scientific validity of the trial design. The DSMB reviews data periodically in order to make an informed risk versus benefit recommendation concerning the continuation, modification, or termination of the trial due to safety concerns. This DSMB review was triggered upon randomization of the 77th patient which marks the 75% enrollment point for the trial.

About the Phase III Study

This clinical study is testing the Delcath PHP Syste
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Two-Year SYNTAX Data Show Comparable Safety Outcomes for Complex Patients Treated With TAXUS(R) EXPRESS(R) Stents and Bypass Surgery
2. July 2009 Mayo Clinic Womens HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals
3. Poniard Pharmaceuticals Announces Positive Cardiac Safety Data From Picoplatin Phase 1 Trial Supporting NDA Filing
4. 5-Year Study Published in Diabetologia Demonstrated Long-Term Safety of Lantus(R) Compared to NPH
5. Sanofi-aventis Stands Behind the Safety of Lantus(R)
6. New Safety Regulations Drive Greater Need for Resources and Expertise at Every Stage of Clinical Development
7. Study Results Present Efficacy and Safety Findings from the PHIRST-1 Study of Patients with Pulmonary Arterial Hypertension Taking Tadalafil Tablets Once Daily
8. AFRESA(R) Phase 3 Pulmonary Function Safety Data in Patients with Diabetes Presented at ADA
9. Researchers Present Safety and Efficacy Results of 429 Patients Treated With Radiofrequency Ablation for Pre-Cancerous Barretts Esophagus
10. Living Donor Kidney Transplants Using Alemtuzumab Pre-Conditioning and Tacrolimus Monotherapy: Long-Term Safety and Efficacy
11. Results and Additional Analyses From Efficacy and Safety Study of Cortheras Relaxin in Acute Heart Failure to be Presented at Heart Failure Congress 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... , Sept. 2, 2014 Isis Pharmaceuticals, ... data from three drugs in its lipid franchise were ... of Cardiology (ESC) Congress in Barcelona Spain ... antisense drugs designed to provide effective and safe therapeutic ... is composed of one commercialized drug and several other ...
(Date:9/2/2014)... , Switzerland , September ... receiving ISO 13485 accreditation, Sophia Genetics has become the ... clinical use of a Next Generation Sequencing (NGS) ... certification represents an important step in raising the ... and brings Sophia Genetics, world-leading Data Driven Medicine ...
(Date:9/2/2014)... Sept. 2, 2014  Sinovac Biotech Ltd. (NASDAQ: ... China , today announced that the Company,s management ... , Morgan Stanley Global Healthcare Conference, to be held ... 10, 2014. , Morgan Stanley Asia Pacific Healthcare Day, ... 11, 2014. , Aegis Healthcare & Technology Conference, to ...
Breaking Medicine Technology:Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 2Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 3Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 4Drugs from Isis' Lipid Franchise Highlighted at European Society of Cardiology Congress 2014 5Sophia Genetics Becomes the First European Company to Obtain CE-IVD Mark for Clinical use of Next Generation Sequencing Bioinformatics Pipeline for Routine Genetic Testing 2Sinovac to Participate in Upcoming Investor Conferences 2
... (Nasdaq: ANTH ), a biopharmaceutical company developing ... autoimmune disorders, will release its first quarter 2012 financial ... Anthera will host a conference call at 8:30 am ... Conference Call Access: Date: Friday, May 4, 2012 Time: 8:30 ...
... for Disease Control reports annual deaths involving opioid pain ... in the United States. In New York and North ... abusing prescription medications continues to rise, sparking attention amongst ... care for those suffering from pain. For these reasons, ...
Cached Medicine Technology:Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 2Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 3Millennium Laboratories Sponsors Educational Programs in Support of Safe Prescribing Practices at Regional Pain Society Conferences 4
(Date:9/2/2014)... NOVAtime Technology, Inc. ( http://www.novatime.com ), a forward-thinking ... Avon Health Center, a long-time NOVAtime 3000 customer ... Time and Attendance / Workforce Management solution ... the NT7000 . , Avon Health Center in ... nursing facility that provides short-term rehabilitation, long-term care, ...
(Date:9/2/2014)... “Harmonicas have been formally used in ... help people with COPD or asthma. At this ... says Dana Keller, PhD, co-inventor of the Pulmonica. ... much the same – improved health with the ... , The three approaches to harmonicas in healthcare ...
(Date:9/2/2014)... New York, NY (PRWEB) September 02, 2014 ... for women are long gone. But even though men shave ... an unhealthy appearance – rough and irritated skin isn’t inevitable, ... Advanced Dermatology P.C. , For decades, skin care ... years have witnessed a surge in men of all ages ...
(Date:9/2/2014)... September 02, 2014 AURO ... Canada announced today the expansion of its leadership team ... first Chief Financial Officer. Liang joins AURO in conjunction ... and will work closely with the operations, product management ... their cloud presence as well as ensuring effective internal ...
(Date:9/1/2014)... (PRWEB) September 02, 2014 BambooIndustry.com is ... products. The company is famous for its high quality ... the company has announced its new range of ... matter of fact, the company has confidence in the ... clients a huge selection of elegant bamboo items and ...
Breaking Medicine News(10 mins):Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 2Health News:Avon Healthcare Upgrades to NOVAtime 4000 Time and Attendance / Workforce Management Solution with NT7000 Smart Clocks 3Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 2Health News:Harmonica Techs, Inventor of the Pulmonica Pulmonary Harmonica, Outlines New Uses for Harmonicas in Healthcare 3Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 2Health News:Rough Isn’t Rugged in Men’s Skin: Dermatology specialist Dr. Joshua Fox with Advanced Dermatology PC offers tips on easy skin maintenance for men 3Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 2Health News:AURO Appoints Kevin Liang as New Chief Financial Officer for Canadian Enterprise Public Cloud 3Health News:BambooIndustry.com: Solid Bamboo Floors Provided At Discounted Rates 2
... VIAP ), a biotechnology company focused on the ... today that,James G. Stewart, senior vice president, chief financial ... Susquehanna Second Annual SIGnificant,Options in Healthcare on Tuesday, March ... in New York. Interested parties may access a live ...
... You know that the HPV (human,papillomavirus) vaccine ... there a,theoretical basis for exploring its use in ... 3-part CME Webcast, assesses this,and other issues associated ... from Sexuality, Reproduction and Menopause (SRM), a clinical,publication ...
... SOUTH SAN FRANCISCO, Calif., Feb. 26 Rigel,Pharmaceuticals, ... it has named,Daniel B. Magilavy, M.D. vice president ... Magilavy will be responsible for the direction and,oversight ... and related autoimmune disorders. Rigel,s R788, oral syk ...
... EntreMed, Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical ... inflammatory diseases, today,announced that James S. Burns, President ... at the Jesup & Lamont Emerging Growth Stock,Conference, ... Resort in,Orlando, Florida on Thursday, February 28, 2008. ...
... /Xinhua-PRNewswire-FirstCall/ -- China Nepstar,Chain Drugstore Ltd. (NYSE: ... drugstore chain in China based on the number ... entered into a definitive agreement to,acquire all of ... by Ningbo New Century Medical Ltd. ("New Century") ...
... XI,AN, China, Feb. 26 /Xinhua-PRNewswire-FirstCall/ -- China,Bionanometer ... company,within the bionanometer industry, will soon introduce ... of scientific verification, research and experiments,on the ... "Anti-influenza Oral,Granules" and the "Influenza Partner.", ...
Cached Medicine News:Health News:Experts Delve Into Issues of HPV Vaccination 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 2Health News:Daniel Magilavy, M.D. Joins Rigel as Vice President of Clinical Research 3Health News:EntreMed to Present at the Jesup & Lamont Emerging Growth Stock Conference 2Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 2Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 3Health News:China Nepstar Chain Drugstore to Acquire 68 Drugstores from Ningbo New Century Medical Ltd. 4Health News:China Bionanometer Industries Corporation Announces New Products for China 2
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
SOLOS Endoscopy shares your commitment to provide every patient with the highest quality care available through our ongoing research and development of advanced surgical instruments and diagnostic so...
... Products are kept in ... are offered as 1-piece ... or extra long lengths. ... insulation, flush ports, rotating ...
... Instruments incorporate a layered design unique in ... monitored to prevent stray electrosurgical burns along ... insulation failure or capacitive coupling; a well-documented ... into all AEM Instruments provides a neutral ...
Medicine Products: